Pelletier R, Nagge J, Gamble J-M. Variation in bleeding risk estimates among online calculators Cross-sectional study of apps used by and for patients with atrial fibrillation. CANADIAN FAMILY PHYSICIAN. 2022;68:E127-E135.

Gamble J-M, McAlister FA, Johnson JA, Eurich DT. Value in Health. Quantifying the impact of drug exposure misclassification due to restrictive drug coverage in administrative databases: A simulation cohort study [Internet]. 2012;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84862908093&partnerID=MN8TOARS

Davis E, Marra C, Gamble J-M, Farrell J, Lockyer J, FitzGerald JM, et al. Trials. Effectiveness of a pharmacist-driven intervention in COPD (EPIC): Study protocol for a randomized controlled trial [Internet]. 2016;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84992108858&partnerID=MN8TOARS

Boussageon R, Gamble J-M, Gueyffier F, Cornu C. Therapie. Clinically relevant efficacy of insulin therapy in patients with type 2 diabetes,Efficacité cliniquement pertinente de l’insulinothérapie chez les patients diabétiques de Type 2 [Internet]. 2013;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84891513444&partnerID=MN8TOARS

Boussageon R, Gamble J-M, Gueyffier F, Cornu C. Therapie. Clinically relevant efficacy of insulin therapy in patients with type 2 diabetes [Internet]. 2013;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84891513444&partnerID=MN8TOARS

Gamble J-M, Hall JJ, Marrie TJ, Sadowski CA, Majumdar SR, Eurich DT. Therapeutics and Clinical Risk Management. Medication transitions and polypharmacy in older adults following acute care [Internet]. 2014;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84896942611&partnerID=MN8TOARS

Alwashmi MF, Fitzpatrick B, Davis E, Farrell J, Gamble J-M, Hawboldt J. Therapeutic Advances in Respiratory Disease. Features of a mobile health intervention to manage chronic obstructive pulmonary disease: a qualitative study [Internet]. 2020;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85090365197&partnerID=MN8TOARS

Pelletier R, Ng K, Alkabbani W, Labib Y, Mourad N, Gamble J-M. Therapeutic Advances in Drug Safety. Adverse events associated with sodium glucose co-transporter 2 inhibitors: an overview of quantitative systematic reviews [Internet]. 2021;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85099858370&partnerID=MN8TOARS

Gamble J-M, Donnan JR, Chibrikov E, Twells LK, Midodzi WK, Majumdar SR. Scientific Reports. Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute Outcomes [Internet]. 2018;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85054774677&partnerID=MN8TOARS

Alkabbani W, Gamble J-M, Eurich DT, Minhas-Sandhu JK, Shah BR, Alsabbagh MWasem, et al. Risk of hospitalization and death associated with sodium glucose cotransporter-2 inhibitors: A comparison with five other classes of antidiabetic drugs. DIABETES & METABOLISM. 2022;48:101305.

Alkabbani W, Gamble JM, Eurich DT, Minhas-Sandu J, Shah BR, Alsabbagh W, et al. Risk of hospitalization and death associated with Sodium Glucose Cotransporter-2 inhibitors: A comparison with five other classes of antidiabetic drugs. Diabetes and Metabolism. 2021;

Amegadzie JE, Gamble J-M, Farrell J, Gao Z. Respiratory Research. Risk of all-cause mortality or hospitalization for pneumonia associated with inhaled β2-agonists in patients with asthma, COPD or asthma-COPD overlap [Internet]. 2022;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85144299296&partnerID=MN8TOARS

Asadi L, Eurich DT, Gamble J-M, Minhas-Sandhu JK, Marrie TJ, Majumdar SR. Respiratory Medicine. Guideline adherence and macrolides reduced mortality in outpatients with pneumonia [Internet]. 2012;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84855891949&partnerID=MN8TOARS

Gamble JM, Traynor RL, Gruzd A, Mai P, Dormuth CR, Sketris IS. Pharmacoepidemiology and Drug Safety. Measuring the impact of pharmacoepidemiologic research using altmetrics: A case study of a CNODES drug-safety article [Internet]. 2020;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85044325731&partnerID=MN8TOARS

Gamble JM, Traynor RL, Gruzd A, Mai P, Dormuth CR, Sketris IS. Pharmacoepidemiology and Drug Safety. Measuring the impact of pharmacoepidemiologic research using altmetrics: A case study of a CNODES drug-safety article [Internet]. 2018;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85044325731&partnerID=MN8TOARS

Gamble J-M, Johnson JA, Majumdar SR, McAlister FA, Simpson SH, Eurich DT. Pharmacoepidemiology and Drug Safety. Evaluating the introduction of a computerized prior-authorization system on the completeness of drug exposure data [Internet]. 2013;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84877605478&partnerID=MN8TOARS

Alwashmi MF, Fitzpatrick B, Davis E, Gamble J-M, Farrell J, Hawboldt J. Perceptions of Health Care Providers Regarding a Mobile Health Intervention to Manage Chronic Obstructive Pulmonary Disease: Qualitative Study. JMIR Mhealth Uhealth. 2019;7(6):e13950.

Gamble J-M, Thomas JM, Twells LK, Midodzi WK, Majumdar SR. Medicine (United States). Comparative effectiveness of incretin-based therapies and the risk of death and cardiovascular events in 38,233 metformin monotherapy users [Internet]. 2016;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84978686237&partnerID=MN8TOARS

Gamble J-M, Butalia S. Medical Practice Variations. Medical Practice Variations in Diabetes Mellitus. 2016;

Gamble J-M, Majumdar SR, Johnson JA, McAlister FA, Simpson SH, Eurich DT. Medical Care. Changes in thiazolidinedione use and outcomes following removal of a prior-authorization policy: Controlled time-series analysis [Internet]. 2014;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84890441981&partnerID=MN8TOARS